Novartis AG
NVS | NYSE
$142.53
+$1.25 (+0.88%)
At close: Sep 23, 2026, 3:43 PM ET
$142.83
+$0.30 (+0.21%)
Pre-market:
Sep 24, 2026, 9:10 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 28, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 7.62B | 6.88B | 11.44B | 9.56B | 6.66B | 7.07B | 11.46B | 13.61B | 7.9B | 9.47B | 13.39B | 12.41B | 10.89B | 12B | 7.52B | 8.73B | 3.63B | 13.85B | 12.41B | 7.21B | 5.12B | 3.8B |
Short-Term Investments | 74M | 100M | 155M | 197M | 344M | 130M | 1.89B | 411M | 532M | 225M | 1.03B | 290M | 289M | 260M | 11.41B | 10.38B | 16.13B | 4.96B | 15.92B | 951M | 239M | 276M |
Long-Term Investments | 2.37B | 2.43B | 2.3B | 2.15B | 2.16B | 2.1B | 1.13B | 2.19B | 2.13B | 2.58B | 2.7B | 2.12B | 2.43B | 2.56B | 2.47B | 2.49B | 2.58B | 2.91B | 3.16B | 12.35B | 12.01B | 11.63B |
Other Long-Term Assets | 5.93B | 4.98B | 10.04B | 4.78B | 4.47B | 4.11B | 4.51B | 1.39B | 1.66B | 1.21B | 1.31B | 1.11B | 1.21B | 1.21B | 1.2B | 3.19B | 3.89B | 3.86B | 2.29B | 2.13B | 2.21B | 1.59B |
Receivables | 9.85B | 9.6B | 10.93B | 8.98B | 9.18B | 8.73B | 8.21B | 8.15B | 8.48B | 8.25B | 8.12B | 7.1B | 9.54B | 9.18B | 8.94B | 8.68B | 8.91B | 8.68B | 8.83B | 8.63B | 8.65B | 8.48B |
Inventory | 6.22B | 6.29B | 6.27B | 6.42B | 6.31B | 5.83B | 5.72B | 5.94B | 5.75B | 5.74B | 5.91B | 5.61B | 8.23B | 7.89B | 7.18B | 6.78B | 6.88B | 7B | 6.67B | 6.89B | 7.11B | 7B |
Other Current Assets | 3.59B | 3.74B | 571M | 3.04B | 3.46B | 3.36B | 1.43B | 3.16B | 3.03B | 2.76B | 1.25B | 20.26B | 4.55B | 2.79B | 958M | 2.39B | 2.59B | 2.75B | 793M | 2.57B | 2.69B | 2.64B |
Total Current Assets | 27.35B | 26.61B | 30.46B | 28.2B | 25.94B | 25.11B | 29.7B | 31.26B | 25.69B | 26.45B | 30.48B | 45.66B | 33.49B | 32.11B | 36.91B | 36.95B | 38.14B | 37.24B | 45.72B | 26.25B | 23.81B | 22.2B |
Property-Plant & Equipment | 12.27B | 12.24B | 12.35B | 11.99B | 11.83B | 11.09B | 10.87B | 11.2B | 10.62B | 10.54B | 10.92B | 10.34B | 12.28B | 12.35B | 12.2B | 11.73B | 12.21B | 12.86B | 13.11B | 13.16B | 13.34B | 13.2B |
Goodwill & Intangibles | 68.84B | 67.03B | 54.98B | 54.59B | 54.79B | 52.44B | 51.67B | 52.83B | 53.01B | 49.34B | 50.22B | 49.83B | 57.53B | 59.93B | 60.95B | 60.56B | 62.48B | 64.49B | 63.78B | 63.52B | 64.58B | 64.97B |
Total Long-Term Assets | 94.68B | 91.93B | 85.11B | 79.09B | 78.46B | 74.83B | 72.54B | 72.26B | 71.81B | 67.89B | 73.34B | 67.04B | 77.49B | 80.13B | 84.86B | 81.51B | 84.77B | 87.98B | 90.17B | 94.96B | 100.21B | 99.55B |
Total Assets | 122.03B | 118.53B | 115.57B | 107.29B | 104.4B | 99.94B | 102.25B | 103.52B | 97.51B | 94.33B | 103.82B | 112.7B | 110.98B | 112.24B | 121.77B | 118.46B | 122.91B | 125.22B | 135.88B | 121.21B | 124.02B | 121.75B |
Account Payables | 4.26B | 4.32B | 4.46B | 4.56B | 4.51B | 4.26B | 4.57B | 4.09B | 4.15B | 4.06B | 4.93B | 3.87B | 5.35B | 5.43B | 5.15B | 4.69B | 4.97B | 5.08B | 5.55B | 4.67B | 4.81B | 5.04B |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 127M | n/a | n/a | n/a | 98M | n/a | n/a | n/a | 123M | n/a | n/a | n/a | 123M | n/a | n/a | n/a |
Short-Term Debt | 9.86B | 7.62B | 5.52B | 7.52B | 8.31B | 7.8B | 8.09B | 6.57B | 7.53B | 8.34B | 6.31B | 5.67B | 8.54B | 7.22B | 6.13B | 7.3B | 7.3B | 6.97B | 6.5B | 9.61B | 9.35B | 10.44B |
Other Current Liabilities | 15.32B | 17.36B | 11.98B | 16.32B | 15.81B | 16.75B | 10.38B | 15.07B | 13.78B | 15.01B | 10.83B | 36.73B | 15.37B | 14.94B | 12.41B | 13.48B | 12.93B | 15.18B | 13.36B | 13.14B | 13.1B | 12.44B |
Total Current Liabilities | 31.75B | 31.37B | 27.28B | 32B | 31.71B | 31.62B | 28.69B | 28.13B | 27.61B | 29.29B | 26.39B | 48.39B | 31.91B | 30.55B | 28.66B | 28.16B | 27.65B | 29.81B | 30.21B | 29.88B | 29.63B | 30.16B |
Long-Term Debt | 37.49B | 37.45B | 29.59B | 22.6B | 22.47B | 21.67B | 21.37B | 23.75B | 19.66B | 17.19B | 18.44B | 18.07B | 18.26B | 20.4B | 20.24B | 19.73B | 22.23B | 22.8B | 22.9B | 23.1B | 24.83B | 25.75B |
Other Long-Term Liabilities | 3.9B | 4.02B | 2.48B | 4.13B | 4.24B | 4.1B | 4.08B | 4.39B | 4.31B | 4.26B | 4.52B | 4.08B | 4.81B | 4.84B | 4.91B | 5.45B | 5.35B | 5.95B | 6.17B | 6.33B | 6.29B | 6.21B |
Total Long-Term Liabilities | 48.34B | 48.23B | 41.74B | 30.54B | 30.63B | 29.87B | 29.43B | 31.95B | 27.99B | 25.29B | 30.68B | 26.06B | 27.14B | 29.55B | 33.69B | 29.41B | 32.26B | 33.71B | 37.85B | 34.39B | 40.25B | 41B |
Total Liabilities | 80.09B | 79.61B | 69.02B | 62.54B | 62.34B | 61.49B | 58.12B | 60.08B | 55.6B | 54.58B | 57.07B | 74.45B | 59.05B | 60.1B | 62.34B | 57.57B | 59.9B | 63.51B | 68.06B | 64.27B | 69.89B | 71.16B |
Total Debt | 49.01B | 47B | 37.11B | 32.02B | 32.64B | 31.27B | 31.26B | 32.16B | 28.99B | 27.28B | 26.35B | 25.19B | 28.34B | 29.2B | 27.91B | 28.54B | 31.09B | 31.34B | 31.03B | 34.33B | 35.85B | 37.84B |
Book Value | 41.95B | 38.93B | 46.55B | 44.75B | 42.05B | 38.45B | 44.13B | 43.44B | 41.9B | 39.76B | 46.75B | 38.25B | 51.93B | 52.14B | 59.42B | 60.9B | 63.01B | 61.7B | 67.82B | 56.94B | 54.13B | 50.59B |
Book Value Per Share | 21.92 | 20.32 | 24.13 | 23.07 | 21.46 | 19.43 | 22.02 | 21.43 | 20.48 | 19.34 | 22.64 | 18.43 | 24.79 | 24.60 | 27.64 | 27.93 | 28.50 | 27.58 | 30.10 | 25.26 | 23.97 | 22.34 |
Common Stock | 736M | 736M | 766M | 766M | 766M | 766M | 793M | 793M | 793M | 793M | 825M | 825M | 842M | 842M | 890M | 890M | 890M | 901M | 901M | 901M | 913M | 913M |
Retained Earnings | 39.65B | 37.25B | 44.72B | 43.51B | 41.53B | 39.84B | 46.56B | 46.29B | 45.84B | 43.83B | 49.65B | 42.33B | 55.68B | 56.09B | 63.54B | 64.54B | 65.43B | 63.45B | 70.99B | 57.44B | 54.4B | 52.05B |
Comprehensive Income | 1.21B | 571M | 694M | 98M | -275M | -2.22B | 43.31B | -3.73B | -4.87B | -4.94B | -3.77B | -4.96B | -4.63B | -4.84B | -5B | -4.54B | -3.34B | -2.75B | -4.19B | -1.52B | -1.21B | -2.38B |
Shareholders Equity | 41.54B | 38.51B | 46.13B | 44.33B | 41.99B | 38.37B | 44.05B | 43.32B | 41.73B | 39.68B | 46.67B | 38.16B | 51.85B | 52.06B | 59.34B | 60.82B | 62.93B | 61.54B | 67.66B | 56.77B | 54.04B | 50.52B |
Total Investments | 2.45B | 2.53B | 2.46B | 2.35B | 2.51B | 2.23B | 3.02B | 2.6B | 2.66B | 2.81B | 3.73B | 2.41B | 2.72B | 2.82B | 13.88B | 12.87B | 18.71B | 7.87B | 19.09B | 13.3B | 12.25B | 11.9B |
Add to Watchlist
Select watchlists to add or remove NVS